Victor Lee

Also affiliated with University of Ottawa, Chinese University of Hong Kong, Queen Mary Hospital, Yale Cancer Center, University of Hong Kong

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population”.

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

Nature Communications(2023)10.1038/s41467-023-38196-z

N/A

0.646DataRank · unranked

73 citations

Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai +95 more

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2814

N/A

0.416DataRank · unranked

15 citations

Zahra Talebi, Elizabeth Winters, Caroline Even, Victor Lee, Maura L. Gillison +8 more

Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.11.019

N/A

0.312DataRank · unranked

6 citations

Chao A. Hsiung, Xiaoyu Wang, Haoyu Zhang, Wei Jie Seow, Jianxin Shi +95 more

Stratifying lung adenocarcinoma risk with multi-ancestry polygenic risk scores in East Asian never-smokers

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf272

N/A

0.104DataRank · unranked

1 citations

Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Kouya Shiraishi +95 more

Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers

medRxiv(2024)10.1101/2024.06.26.24309127

N/A

0DataRank · unranked

0 citations

Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Kouya Shiraishi +95 more

Phase I/IIa clinical trial of a small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein Barr virus–positive nasopharyngeal cancer with pharmacokinetic and pharmacodynamic correlative studies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6035

N/A

0DataRank · unranked

4 citations

Michelle A. Rudek, Caroline Even, Victor Lee, Maura L. Gillison, Saad A. Khan +6 more

Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma

Research Square(2020)10.21203/rs.3.rs-36929/v2

N/A

0DataRank · unranked

3 citations

Vivian Wai Yan Lui, Yongshu Li, Lin Jia, Chanping You, Xin Li +10 more

Factors associated with the use of adjuvant radiation therapy in stage III melanoma

Frontiers in Oncology(2023)10.3389/fonc.2023.1005930

N/A

0DataRank · unranked

3 citations

Victor Lee, Beverly Yu, Fatima N. Mirza, Cheryl K. Zogg, Daniel Yang +4 more

Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma

Journal of Experimental & Clinical Cancer Research(2020)10.1186/s13046-020-01763-z

N/A

0DataRank · unranked

28 citations

Vivian Wai Yan Lui, Yongshu Li, Lin Jia, Chanping You, Xin Li +10 more